Vitamin B 12 is a water-soluble molecule essential for mammalian intracellular metabolism. Its two metabolically active forms, methyl-cobalamin and 5-deoxyadenosylcobalamin, are coenzymes in the reactions catalyzed, respectively, by methionine synthase and methylmalonylCoA mutase.
Vitamin B 12 is a water-soluble molecule essential for mammalian intracellular metabolism. Its two metabolically active forms, methyl-cobalamin and 5-deoxyadenosylcobalamin, are coenzymes in the reactions catalyzed, respectively, by methionine synthase and methylmalonylCoA mutase.
There are two vitamin B 12 carrier proteins in serum, haptocorrin and transcobalamin (TC). Haptocorrin binds the majority of serum B 12 but, unlike TC, does not deliver the vitamin to metabolically active cells. Only 5-20% of serum B 12 is bound to TC as "holo-TC". Current laboratory assays determine total serum B 12 concentrations and are relatively poor indicators of the ability of serum to deliver the vitamin to tissues.
Methods are now available to measure holo-TC in clinical samples (1) (2) (3) . Although information exists for "between-person" variations in holo-TC concentrations, (2, 4 ) , very few data exist regarding its "within-person" variability (5 ) . Such knowledge will be essential for studies of diseases potentially associated with low concentrations of holo-TC, such as Alzheimer disease (6 ) . We therefore examined the between-and within-person variability and within-assay variability of holo-TC concentrations in healthy elderly volunteers in the fasting and nonfasting states.
The study received local research ethics committee approval and followed an established protocol aimed at minimizing various preanalytical factors that can influence the results of clinical laboratory tests (7 ) . Because valid estimates of the components of variation can be obtained from a relatively small number of participants (7 ), six males and six females age Ն65 years were recruited. Their mean age was 82.5 years (range, 65-99 years). Ages were not significantly different between males and females (Student t-test, t 10 ϭ 1.4; P ϭ 0.2). The participants were all maintaining their usual lifestyles and not taking any medication. Ten samples of venous blood were collected at 14-day intervals from each participant over a 5-month period. The same individual (a trained nurse) collected venous blood samples from fasted and seated individuals at the same time of day (between 0800 and 0930). On the last two sampling occasions, blood was also collected 3-4 h postprandially. All sample collection tubes were from a single batch.
Sample handling and storage at Ϫ30°C were performed according to a preset fixed protocol; samples were processed and stored within 1 h of venipuncture. To minimize analytical variation, we assayed all samples from each individual in a single batch. A single analyst (R.E.) assayed all of the samples with the same instrument, reagents, calibrators, and quality-control materials. Each sample was analyzed twice. Because the manufacturer's guidelines (Axis-Shield) already recommend assaying each sample in duplicate, to achieve this, we assayed two pairs of replicates. Each assay had one duplicate of two concentrations of manufacturer's quality-control material at the beginning and end of the assay. The Axis-Shield assay is a competitive protein-binding assay. Samples are pretreated with magnetic particles coated with monoclonal antibodies to human TC. When a magnetic separation rack is used, holo-TC is retained after the haptocorrin-containing supernatant is discarded. The magnetic particles are treated with a reducing and denaturing reagent to release free B 12 , which is then measured by means of a Co-57-labeled tracer and porcine intrinsic factor binder. Using calibrators prepared from recombinant human holo-TC, one can measure the concentration of holo-TC in each sample.
To analyze a complete set of samples from two participants in the same assay, the number of tubes used was increased from the maximum reagent-set size of 100 to 118. Reagents from two reagent sets of the same lot number were pooled to accommodate this increased assay size. On the day of each assay, samples were thawed at room temperature and thoroughly mixed. The positions of the duplicates from each participant were randomized to minimize any potential inherent positional or timerelated difference within the assay.
One person defaulted after donating six samples. Six sets of replicates were incomplete because of limited volumes of serum and were rejected. Five sets of replicates containing a single noticeably discrepant concentration (115, 389, 237, 1, and 3 pmol/L, respectively) were also rejected.
A generalized estimating equation model (module GEE of the statistical programming language "R" (8 ) was used to study the age dependence of holo-TC (9 ). Holo-TC decreased with age: holo-TC ϭ 109.6 pmol/L Ϫ 0.82 ϫ age [95% confidence interval (CI) of regression parameter, Ϫ1.55 to Ϫ0.07; P ϭ 0.02].
Means and ranges of participants' fasting and nonfasting holo-TC values are shown in Fig. 1 . Data from participant 4 was rejected according to Reed's criterion: the difference between the extreme value and the next highest (or lowest) value exceeded one-third of the range of all values (7 ). In the remaining individuals, females had higher holo-TC concentrations than males (Table 1 ; 95% CI for difference between means, 9.7-16.9 pmol/L; Student t-test, t 243 ϭ 6.6; P Ͻ0.0001). Holo-TC concentrations were, on average, just over 2 pmol/L higher in fasting samples (collected between 0800 and 0930) compared with nonfasting samples (collected between 1100 and 1230; Table 1 and two-way ANOVA, with "partici-pant" and "fasting" as categorical variables, F 1,222 ϭ 7.18; P ϭ 0.008).
To calculate analytical, interindividual, and intraindividual components of variance, we performed a nested ANOVA (Variance Components module of Statistica/W; Statsoft Inc.). The model used was Patient, Sample, and Replicate nested one within the other. In Table 1 are the indices derived from the results of the ANOVA. The analytical, intraindividual, and interindividual CV (CV A , CV I , and CV G , respectively) were calculated as described by Fraser and Harris (7 ) . The index of individuality (II) was calculated as the ratio of CV I /CV G , and the reliability coefficient (RC) was calculated as the between-participant variance divided by the total variance (10 ): CV G 2 /(CV A 2 ϩ CV I 2 ϩ CV G 2 ). CV I and CV A may be used to determine whether percentage changes in serial results are significant at a given level of probability (10 ). This critical difference has been called the reference change value (RCV), and for P ϭ 0.05, RCV was calculated as 2 1/2 ‫ء‬ 1.96 ‫ء‬ (CV A 2 ϩ CV I 2 ) 1/2 ( Table 1 ). "High" and "Low" control material was included in duplicate at the start and end of each batch. The withinbatch CV was calculated from the differences between the "before" and "after" batch samples, and between-batch CV as the overall SD of all 12 controls. Both the withinbatch and the between-batch CV for low controls was 9.1%. The respective values for high controls were 8.2% and 12%. These values for within-and between-batch imprecision were higher than those reported by Ulleland et al. (2 ) and Loikas et al. (4 ) , perhaps because of the increase in assay size to accommodate complete sample sets from two participants within the same assay. Additional information on the performance of the assay may be derived from a comparison of CV I and CV A . It has been suggested that the "desirable" specification for an assay should be that the analytical variation is less than one-half that of the within-participant biological variation (CV A Ͻ0.5CV I ) (10 ) . This compares with the definition of "optimum" performance as CV A Ͻ0.25CV I and "minimum" performance as CV A Ͻ0.75CV I . In our experience, the performance of the assay approximated desirable specification with CV A ϭ 0.52 CV I .
Our finding of an intraindividual variation for holo-TC of 16% in fasting participants is comparable to a value of 16% calculated over a 3-month period in a substudy of the Western Norway B-vitamin intervention trial (5 ). Similarly, our finding of higher holo-TC in females compared with males has been reported in other studies (4, 11 ) . The finding of an age-related decrease in holo-TC has been noted in some, but not all, studies (4, 12 ) .
It was perhaps surprising that holo-TC concentrations were lower in postprandial samples. In a study of diurnal variation of holo-TC, Bjorkesten et al. (13 ) observed increasing holo-TC concentrations between 0600 and 1200 followed by a subsequent decrease. Our results might reflect the time of day that samples were collected rather than a fasting/nonfasting effect per se.
Holo-TC reference intervals were recently determined from a sample of 303 healthy adults and elderly (4 ). Holo-TC, however, has a relatively low II of 0.51. When the II is low, particularly when it is Ͻ0.6, the dispersion of values for any individual will span only a small part of any reference interval. Conversely, an II of 1.4 is considered the critical value at which the distribution of values from a single individual covers much of the entire distribution (14 ) . One device for increasing the II is by stratification of reference intervals, perhaps by gender. Stratification of our data by gender yielded an increase of II to 1.07 in females and a decrease to 0.38 in males (Table 1) . Holo-TC reference intervals may, therefore, be of limited use, as is true for many other biological measures (10 ) . Their diagnostic utility in conjunction with other markers of B 12 status remains to be explored (1 ) . A change in an individual's holo-TC concentration is probably more significant than the determination of absolute concentrations. Indeed, Nexo et al. Regression dilution describes the attenuation in a regression coefficient when a single measured value of a covariate is used instead of the usual or mean value over a period of time. The simple method of adjusting regression coefficients for this dilution arises out of measurement error theory and is easily implemented (15 ) . In the case of a single covariate (simple linear regression), correction for regression dilution is achieved by multiplying the regression coefficient by a correction factor. The correction factor is simply the inverse of the RC. For holo-TC, it is 1.26, comparable to a value of 1.14 obtained for homocysteine (16 ) . The adjusted regression coefficient is, therefore, larger than the naive coefficient; crosssectional studies that use regression analysis based on a single assay of holo-TC may therefore underestimate the magnitude of any risk associations with disease by ϳ26% in an elderly population.
Our results confirm that, in an elderly population and under the conditions used, this particular holo-TC assay has a desirable quality specification, with analytical variation being approximately one-half that of within-participant biological variation. The results also provide essential information for the interpretation of holo-TC values in both cross-sectional and longitudinal studies in the elderly.
The University of Liverpool funded this study. We are grateful to the kind volunteers of Gardden Road Surgery Rhosllanerchrugog and to Edward Valente of Axis-Shield for assistance in providing the holo-TC assay reagent sets. Intercellular adhesion molecule-1 (ICAM-1) and E-, P-, and L-selectin are cellular adhesion molecules involved in the recruitment of leukocytes on the activated vessel wall during inflammation (1 ) and play an important role in the early stages of atherosclerosis and its complications (2 ) . Thus, the measurement of soluble adhesion molecules in serum may have diagnostic relevance in many inflammatory diseases (3 ) . A profile of soluble adhesion molecule concentrations may allow better therapeutic decisions in inflammatory and autoimmune disorders, infection, cancer, and cardiovascular pathologies and may also aid in the prediction of cardiovascular events (4, 5 ) . However, the use of these markers in clinical practice depends critically on knowledge of their reference values.
Age
The purpose of the present study was to establish ageand sex-specific reference intervals for serum concentrations of soluble ICAM-1 and E-, P-, and L-selectin in healthy children (4 -17 years) and adults (18 -55 years).
Blood samples were taken from healthy individuals (157 boys and 146 girls 4 -17 years of age and 245 men and 250 women 18 -55 years of age) who were members of the Stanislas cohort (6 ) . Participants were of French origin (Vosges and Meurthe et Moselle); free from serious and/or chronic illnesses, especially cardiovascular, hepatic, or renal diseases; and were not on treatment with lipid-lowering drugs. Volunteers with aspartate aminotransferase, alanine aminotransferase, or ␥-glutamyltransferase activities Ͼ200 U/L, apolipoprotein E concentrations Ͼ200 mg/L, orosomucoid or haptoglobin
